secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001104659-23-082871
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition regains Nasdaq MVLS compliance threshold
------------------------------------------------------------

- Received Nasdaq notice on June 14, 2023 for non-compliance with $35M MVLS requirement.
- Nasdaq confirmed MVLS >=$35M for 15 consecutive business days (June 26-July 14, 2023).
- On July 17, 2023, Nasdaq notified compliance is regained; matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923082871/0001104659-23-082871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923082871/tm2321746d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-082871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer